Sodium-lithium countertransport and triglycerides in diabetic nephropathy

R. Mangili, G. Zerbini, C. Barlassina, D. Cusi, G. Pozza

Research output: Contribution to journalArticle

Abstract

Elevated erythrocyte sodium-lithium countertransport (SLC) activity is an intermediate phenotype of essential hypertension among Caucasians, and is controversially associated with nephropathy in Type 1 (insulin-dependent) diabetes. Hypertriglyceridemia is a frequent concomitant of elevated SLC in the general population, and may be found in diabetic nephropathy. The present study was designed to investigate the influence of kidney disease, serum triglycerides and blood pressure on the interindividual variability of SLC in Type 1 diabetes. SLC and fasting major serum lipids were studied in 35 Type 1 diabetic patients with persistently elevated urinary albumin excretion and in a group of patients matched for age, sex and duration of diabetes, but with normoalbuminuria. SLC was elevated in patients with clinical nephropathy (N = 10; median: 420 μmol · l(RBC)-1 · hr-1) and in patients with microalbuminuria (N = 25; median: 405 μmol · l(RBC)-1 · hr-1) compared with normoalbuminuric patients (median: 296 μmol · l(RBC)-1 · hr-1; P <0.01 vs. both groups). Hypertriglyceridemia and hypercholesterolemia were found only among patients with macroalbuminuria. Analysis of covariance indicated that the association of elevated SLC with kidney disease (P <0.006 in all models) was largely independent of serum triglycerides, but also of total cholesterol, insulin dose and measures of glycemic control. Only diastolic blood pressure was positively associated with SLC (P <0.02) independently from nephropathy (P <0.005) also after restricting analysis to the normoalbuminuric patients. Kidney disease and raised blood pressure remain major concomitants of elevated SLC in Type 1 diabetics.

Original languageEnglish
Pages (from-to)127-133
Number of pages7
JournalKidney International
Volume44
Issue number1
Publication statusPublished - 1993

Fingerprint

Diabetic Nephropathies
Lithium
Triglycerides
Sodium
Kidney Diseases
Blood Pressure
Hypertriglyceridemia
Serum
Insulin
Hypercholesterolemia
Type 1 Diabetes Mellitus
Albumins
Fasting
Research Design
Erythrocytes
Cholesterol
Phenotype
Lipids
Population

ASJC Scopus subject areas

  • Nephrology

Cite this

Mangili, R., Zerbini, G., Barlassina, C., Cusi, D., & Pozza, G. (1993). Sodium-lithium countertransport and triglycerides in diabetic nephropathy. Kidney International, 44(1), 127-133.

Sodium-lithium countertransport and triglycerides in diabetic nephropathy. / Mangili, R.; Zerbini, G.; Barlassina, C.; Cusi, D.; Pozza, G.

In: Kidney International, Vol. 44, No. 1, 1993, p. 127-133.

Research output: Contribution to journalArticle

Mangili, R, Zerbini, G, Barlassina, C, Cusi, D & Pozza, G 1993, 'Sodium-lithium countertransport and triglycerides in diabetic nephropathy', Kidney International, vol. 44, no. 1, pp. 127-133.
Mangili, R. ; Zerbini, G. ; Barlassina, C. ; Cusi, D. ; Pozza, G. / Sodium-lithium countertransport and triglycerides in diabetic nephropathy. In: Kidney International. 1993 ; Vol. 44, No. 1. pp. 127-133.
@article{1ed8851280f54ed89eb21ed447c94f65,
title = "Sodium-lithium countertransport and triglycerides in diabetic nephropathy",
abstract = "Elevated erythrocyte sodium-lithium countertransport (SLC) activity is an intermediate phenotype of essential hypertension among Caucasians, and is controversially associated with nephropathy in Type 1 (insulin-dependent) diabetes. Hypertriglyceridemia is a frequent concomitant of elevated SLC in the general population, and may be found in diabetic nephropathy. The present study was designed to investigate the influence of kidney disease, serum triglycerides and blood pressure on the interindividual variability of SLC in Type 1 diabetes. SLC and fasting major serum lipids were studied in 35 Type 1 diabetic patients with persistently elevated urinary albumin excretion and in a group of patients matched for age, sex and duration of diabetes, but with normoalbuminuria. SLC was elevated in patients with clinical nephropathy (N = 10; median: 420 μmol · l(RBC)-1 · hr-1) and in patients with microalbuminuria (N = 25; median: 405 μmol · l(RBC)-1 · hr-1) compared with normoalbuminuric patients (median: 296 μmol · l(RBC)-1 · hr-1; P <0.01 vs. both groups). Hypertriglyceridemia and hypercholesterolemia were found only among patients with macroalbuminuria. Analysis of covariance indicated that the association of elevated SLC with kidney disease (P <0.006 in all models) was largely independent of serum triglycerides, but also of total cholesterol, insulin dose and measures of glycemic control. Only diastolic blood pressure was positively associated with SLC (P <0.02) independently from nephropathy (P <0.005) also after restricting analysis to the normoalbuminuric patients. Kidney disease and raised blood pressure remain major concomitants of elevated SLC in Type 1 diabetics.",
author = "R. Mangili and G. Zerbini and C. Barlassina and D. Cusi and G. Pozza",
year = "1993",
language = "English",
volume = "44",
pages = "127--133",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Sodium-lithium countertransport and triglycerides in diabetic nephropathy

AU - Mangili, R.

AU - Zerbini, G.

AU - Barlassina, C.

AU - Cusi, D.

AU - Pozza, G.

PY - 1993

Y1 - 1993

N2 - Elevated erythrocyte sodium-lithium countertransport (SLC) activity is an intermediate phenotype of essential hypertension among Caucasians, and is controversially associated with nephropathy in Type 1 (insulin-dependent) diabetes. Hypertriglyceridemia is a frequent concomitant of elevated SLC in the general population, and may be found in diabetic nephropathy. The present study was designed to investigate the influence of kidney disease, serum triglycerides and blood pressure on the interindividual variability of SLC in Type 1 diabetes. SLC and fasting major serum lipids were studied in 35 Type 1 diabetic patients with persistently elevated urinary albumin excretion and in a group of patients matched for age, sex and duration of diabetes, but with normoalbuminuria. SLC was elevated in patients with clinical nephropathy (N = 10; median: 420 μmol · l(RBC)-1 · hr-1) and in patients with microalbuminuria (N = 25; median: 405 μmol · l(RBC)-1 · hr-1) compared with normoalbuminuric patients (median: 296 μmol · l(RBC)-1 · hr-1; P <0.01 vs. both groups). Hypertriglyceridemia and hypercholesterolemia were found only among patients with macroalbuminuria. Analysis of covariance indicated that the association of elevated SLC with kidney disease (P <0.006 in all models) was largely independent of serum triglycerides, but also of total cholesterol, insulin dose and measures of glycemic control. Only diastolic blood pressure was positively associated with SLC (P <0.02) independently from nephropathy (P <0.005) also after restricting analysis to the normoalbuminuric patients. Kidney disease and raised blood pressure remain major concomitants of elevated SLC in Type 1 diabetics.

AB - Elevated erythrocyte sodium-lithium countertransport (SLC) activity is an intermediate phenotype of essential hypertension among Caucasians, and is controversially associated with nephropathy in Type 1 (insulin-dependent) diabetes. Hypertriglyceridemia is a frequent concomitant of elevated SLC in the general population, and may be found in diabetic nephropathy. The present study was designed to investigate the influence of kidney disease, serum triglycerides and blood pressure on the interindividual variability of SLC in Type 1 diabetes. SLC and fasting major serum lipids were studied in 35 Type 1 diabetic patients with persistently elevated urinary albumin excretion and in a group of patients matched for age, sex and duration of diabetes, but with normoalbuminuria. SLC was elevated in patients with clinical nephropathy (N = 10; median: 420 μmol · l(RBC)-1 · hr-1) and in patients with microalbuminuria (N = 25; median: 405 μmol · l(RBC)-1 · hr-1) compared with normoalbuminuric patients (median: 296 μmol · l(RBC)-1 · hr-1; P <0.01 vs. both groups). Hypertriglyceridemia and hypercholesterolemia were found only among patients with macroalbuminuria. Analysis of covariance indicated that the association of elevated SLC with kidney disease (P <0.006 in all models) was largely independent of serum triglycerides, but also of total cholesterol, insulin dose and measures of glycemic control. Only diastolic blood pressure was positively associated with SLC (P <0.02) independently from nephropathy (P <0.005) also after restricting analysis to the normoalbuminuric patients. Kidney disease and raised blood pressure remain major concomitants of elevated SLC in Type 1 diabetics.

UR - http://www.scopus.com/inward/record.url?scp=0027196353&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027196353&partnerID=8YFLogxK

M3 - Article

C2 - 8355453

AN - SCOPUS:0027196353

VL - 44

SP - 127

EP - 133

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 1

ER -